Growth differentiation factor-15 as a non-invasive biomarker of liver fibrosis in sickle cell disease
International Journal of Hematology · 2025
DOI: 10.1007/s12185-025-04035-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Hematology, 2025. Verfasst von Konstantinos Manganas und 4 weiteren Autor:innen. Beteiligte Einrichtung: Thalassemia and Sickle Cell Unit, Hippokration General Hospital, 114 Vas. Sofias, 11527, Athens, Greece. kmagganas92@gmail.com. Hauptthemen laut MEDLINE: Growth Differentiation Factor 15, Anemia, Sickle Cell, Liver Cirrhosis. Die Arbeit nennt 32 Literaturangaben.
Abstract (Originalsprache)
This study aimed to evaluate the relationship between growth differentiation factor-15 (GDF-15) levels and liver fibrosis in patients with sickle cell disease (SCD) and assess the diagnostic performance of GDF-15 as a non-invasive biomarker. Thirty patients with SCD were categorized into two groups based on fibrosis severity (≥ F2 vs. < F2) determined by Fibroscan, AST to Platelet Ratio Index (APRI) and FIB-4. GDF-15 levels were compared between groups, and independent predictors of GDF-15 were identified by multiple linear regression. Patients with significant liver fibrosis (≥ F2) had significantly higher GDF-15 levels. Multivariate linear regression revealed that GDF-15 concentration was independently associated with liver elastography values (β = 0.619, p = 0.002). The area under the curve for detecting significant fibrosis using GDF-15 as a diagnostic test was 0.835 (95% CI: 0.686-0.983, p = 0.002). A GDF-15 cut-off of 4200 pg/ml had a positive predictive value of 73.6%, a negative predictive value of 81.8%, sensitivity of 87.5% and specificity of 64.3%. In conclusion, GDF-15 is strongly associated with liver fibrosis in SCD and demonstrates high diagnostic accuracy as a non-invasive biomarker. Given its role in inflammation, oxidative stress, and iron metabolism, GDF-15 may serve as a valuable tool for early fibrosis detection and disease monitoring.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Thalassemia and Sickle Cell Unit, Hippokration General Hospital, 114 Vas. Sofias, 11527, Athens, Greece. kmagganas92@gmail.com.
- Thalassemia and Sickle Cell Unit, Hippokration General Hospital, 114 Vas. Sofias, 11527, Athens, Greece.
- Second Department of Internal Medicine and Research Laboratory, Medical School, National and Kapodistrian University of Athens, Hippokration General Hospital, Athens, Greece.
Zitieren
APA
Manganas, K., Delicou, S., Hadziyannis, E., Giannouli, S., & Koskinas, J. (2025). Growth differentiation factor-15 as a non-invasive biomarker of liver fibrosis in sickle cell disease. International Journal of Hematology. https://doi.org/10.1007/s12185-025-04035-8
Vancouver
Manganas K, Delicou S, Hadziyannis E, Giannouli S, Koskinas J. Growth differentiation factor-15 as a non-invasive biomarker of liver fibrosis in sickle cell disease. International Journal of Hematology. 2025. doi:10.1007/s12185-025-04035-8
BibTeX
@article{Manganas2025,
author = {Manganas, Konstantinos and Delicou, Sophia and Hadziyannis, Emilia and Giannouli, Stavroula and Koskinas, John},
title = {Growth differentiation factor-15 as a non-invasive biomarker of liver fibrosis in sickle cell disease},
journal = {International Journal of Hematology},
year = {2025},
doi = {10.1007/s12185-025-04035-8}
}
EUVIMED